山东省治疗小儿羊癫疯病方法(山东羊羔疯病的治疗偏方) (今日更新中)

Walmart and Target are being sued for allegedly selling toys with lead levels up to 10 times more than the federal limit of 100 parts per million, New York Attorney General Barbara D. Underwood announced on Thursday. According to a statement released by Underwood's office, the AG's office was able to find Cra-Z-Jewelz jewelry-making kits from stores. The kits allegedly contained lead at levels of 120 to 980 parts per million. The Attorney General's office had further independent testing done to confirm the results. The toy's maker, LaRose Industries, which is also a plaintiff in the New York lawsuit, issued a national recall. Underwood's office is accusing Walmart, Target and LaRose of "repeated illegality and fraud under New York State law by committing thousands of violations of state law prohibitions on importing, distributing, and selling hazardous toys; deceiving consumers; and false advertising."Underwood's office is seeking civil penalties of  to ,000 for each Cra-Z-Jewelz kit the companies sought to sell in the state.“No parent should have to worry that their child’s toy may be toxic. As we allege, these companies imported and sold toys with dangerous levels of toxic lead – jeopardizing the health of New York’s children and breaking the law,” Underwood said in a statement. “Our lawsuit seeks to hold these companies accountable for the failures that allowed lead-contaminated toys on store shelves, while forcing them to take responsibility for the safety of the products they sell.”The suit also seeks to force the companies to adhere to higher quality control standards to prevent toys with high lead levels from being purchased. The CDC says that lead in children's blood has been shown to affect IQ, ability to pay attention, and academic achievement. The CDC added that children under the age of 6 years old are at most risk of lead poisoning.  1936

WASHINGTON — The U.S. government on Tuesday will start distributing 30,000 doses of an experimental monoclonal antibody drug to fight COVID-19, the one President Donald Trump received last month.Over the weekend, the Food and Drug Administration agreed to allow emergency use of the therapeutic, casirivimab and imdevimab, made by Regeneron Pharmaceuticals Inc., for people with mild-to-moderate symptoms who are at high risk of developing serious illness because of their age or other medical conditions.The treatment was not authorized for use in sicker, hospitalized patients or those who need extra oxygen.President Donald Trump was given the therapeutic treatment when he contracted coronavirus in October. The Department of Health and Human Services said the federal government announced funding over the summer to support large-scale manufacturing of casirivimab and imdevimab.The agency will allocate “these government-owned doses to state and territorial health departments which, in turn, will determine which healthcare facilities receive the infusion drug,” reads a statement from HHS.“Beginning immediately, weekly allocations to state and territorial health departments will be proportionally based on confirmed COVID-19 cases in each state and territory over the previous seven days, based on data hospitals and state health departments enter into the HHS Protect data collection platform,” reads the HHS statement.Antibodies bind to the virus and help the immune system eliminate it. The Regeneron drug is a combo of two antibodies that seemed to do this well in lab tests.The emergency use authorization allows limited use of a drug while studies continue to test its safety and effectiveness. Early results suggest it may reduce COVID-19-related hospitalization or emergency room visits.The drugs are given as a one-time treatment through an IV and takes about an hour.Under federal contracts, the drugs for now will be supplied for free, although patients may have to pay part of the cost of the IV treatment. 2036

WASHINGTON — The Supreme Court has ruled that the Trump administration can deport some people seeking asylum without allowing them to make their case to a federal judge. The high court’s 7-2 decision applies to people who fail their initial asylum screenings, making them eligible for quick deportation, or expedited removal. ACLU attorney Lee Gelernt argued against the case and said the ruling will put lives in danger."This ruling fails to live up to the Constitution’s bedrock principle that individuals deprived of their liberty have their day in court, and this includes asylum seekers. This decision means that some people facing flawed deportation orders can be forcibly removed with no judicial oversight, putting their lives in grave danger," Gelernt said.The justices ruled in the case of man who said he fled persecution as a member of Sri Lanka’s Tamil minority, but failed to persuade immigration officials that he faced harm if he returned to Sri Lanka. The man was arrested soon after he slipped across the U.S. border from Mexico. 1055

WASHINGTON — The Washington D.C. Department of Health has released an open letter appealing to all White House staff and those attending a Sept. 26 event in the Rose Garden to seek medical advice and take a coronavirus test.The letter indicates a lack of confidence in the White House medical team’s contact tracing efforts for the virus outbreak that infected President Donald Trump, multiple senior staff members and two U.S. senators, among others.Co-signed by nine other local health departments from neighboring jurisdictions in Maryland and Virginia, the letter says contact tracing on the outbreak has been insufficient and “there may be other staff and residents at risk for exposure to COVID positive individuals.”The move highlights the public health dilemma faced by Mayor Muriel Bowser’s administration regarding the current outbreak. The Trump White House has operated for months in open violation of several D.C. virus regulations, hosting multiple gatherings that exceeded the local 50-person limit and where many participants didn’t wear masks. 1068

WASHINGTON — The Supreme Court has refused to block the execution of four federal prison inmates who are scheduled to be put to death in July and August. The executions would mark the first use of the death penalty on the federal level since 2003. The justices rejected an appeal from four inmates who were convicted of killing children. The court’s action leaves no obstacles standing in the way of the executions, the first of which is scheduled for July 13. The inmates are separately asking a federal judge in Washington to impose a new delay on their executions over other legal issues that have yet to be resolved. 628

来源：资阳报